Evidence map›Paper›PMID 42315841›Full record

ArticleNature communications2026

SplitSeek-Pro: accurate prediction of splittable sites on protein structures.

Yu-Xiang Wang, Fengyi Jiang, Tingjie Xu, Lan-Xin Xing, Yajie Liu, Zhiwei Nie, Jie Chen, Wen-Bin Zhang

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yu-Xiang WangBeijing National Laboratory for Molecular Sciences, Peking University, Beijing, P. R. China.
Fengyi JiangBeijing National Laboratory for Molecular Sciences, Peking University, Beijing, P. R. China.ORCID 0000-0003-1854-1641
Tingjie XuBeijing National Laboratory for Molecular Sciences, Peking University, Beijing, P. R. China.
Lan-Xin XingBeijing National Laboratory for Molecular Sciences, Peking University, Beijing, P. R. China.
Yajie LiuBeijing National Laboratory for Molecular Sciences, Peking University, Beijing, P. R. China.
Zhiwei NieSchool of Electronic and Computer Engineering, Peking University, Shenzhen, P. R. China.ORCID 0000-0002-2781-5248
Jie ChenSchool of Electronic and Computer Engineering, Peking University, Shenzhen, P. R. China.ORCID 0000-0002-9765-4523
Wen-Bin ZhangBeijing National Laboratory for Molecular Sciences, Peking University, Beijing, P. R. China. wenbin@pku.edu.cn.ORCID 0000-0002-8746-0792

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Understanding protein architecture and predicting its structural tolerance to profound remodeling is pivotal for engineering functional proteins. We present SplitSeek-Pro, a deep learning model that evaluates amino acid-level splittability in folded proteins, a property critical for protein engineering tasks such as circular permutation and split reconstitution. By integrating primary sequences with 3D structural features, SplitSeek-Pro achieves residue-resolution predictions through a two-stage training process: large-scale pre-training followed by high-quality fine-tuning. Experimental validation on three distinct proteins confirms its superior predictive power over existing methods. Notably, SplitSeek-Pro identifies characteristic segments that function as cohesive, integral fragments analogous to super-secondary structural motifs. These results establish SplitSeek-Pro as a robust tool for rational protein engineering and offer insights into the fundamental structural building blocks of protein folding. To facilitate community access, we provide an automated web server at http://splitseek.topo.bio .

Indexed as

Deep LearningProteinsSoftwareAmino Acid SequenceModels, MolecularProtein ConformationProtein EngineeringProtein FoldingProteins

Identifiers

PMID42315841
PMCPMC13486474

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.